All CRO News
SCM TO DELIVER VIAL FILLING PROJECT
SCM Pharma Ltd (2nd February 2012): UK-based SCM Pharma is to develop and manufacture an injectable neonatal product for BrePco BioPharma to be used in a clinical trial researching the treatment of critically ill premature babies suffering from hypotension. Ireland-based BrePco selected... Read more
iNovacia announces collaboration with Agios Pharmaceuticals
iNovacia AB (27th January 2012): iNovacia AB, the provider of small molecule drug discovery services, today announced that it has entered into a high-throughput screening collaboration with Agios Pharmaceuticals, Cambridge (MA), USA. Under the agreement, iNovacia will provide small... Read more
A Smarter Approach to CRO +
Synergy (26th January 2012): In today's rapidly changing environment, increasing demand for value is re-shaping the CRO landscape. As part of a major brand refresh, within the SRG group of companies, we are bringing together Satellite and Synergy to create a stronger, consolidated... Read more
Clinical Outsourcing Strategies in 2012: Find the Niche
CROS NT (26th January 2012): The CRO market is projected to grow again in 2012 due to the pharmaceutical industry’s increased investment in outsourcing. When it comes to choosing a CRO, drugmakers want the niche vendors. The Contract Research Organization market is one that seems... Read more
CROS NT Takes Full Ownership In Company, CEO Buys Remaining Shares
CROS NT (26th January 2012): As part of the CROS NT’s mission to become the number one centre of excellence for clinical data services and technology in Europe, CEO Paolo Morelli, who was already the majority shareholder of CROS NT, has decided to purchase the remanining shares... Read more
ICON Strengthens Global Scientific Council with the Appointments of Professor Brendan Buckley and Dr. Nicholas Alp
ICON plc (24th January 2012): Dublin, Ireland, January 24, 2012 – ICON plc (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Professor Brendan... Read more
TGA Sciences and Sanguine Biosciences ink co-marketing agreement to expand presence in Bioassay Development.
TGA Sciences Inc (23rd January 2012): City, State/Country - Month Day, Year: Medford, MA- January 23, 2012 Body: TGA Sciences, Inc (“TGA”) and Sanguine BioSciences, Inc (“Sanguine”) have entered into a co-marketing agreement, in which Sanguine will market TGA’s Bioassay Development services... Read more
790 early phase clinical research beds go with ALPHADAS in Q4 of 2011!
Logos Technologies Ltd (17th January 2012): Logos Technologies achieves significant milestones in 2011. Quarter four ends with Logos seeing a significant endorsement from the market. Four North American sites have chosen ALPHADAS, Logos Technologies market leading eSource, proactive EDC & site... Read more
Excellence in proving your concept: Meet CRST at Biotech Clinical Outsourcing Partnerships, Munich, Germany, 1st -2nd Fe
Clinical Research Services Turku (16th January 2012): CRST Clinical Research Services Turku (16th January 2012): Director of CRST and Professor of Pharmacology, Mika Scheinin, will give a presentation about “PET imaging in neuropsychiatric drug development” which covers the following subjects: •Pharmacokinetics,... Read more
Fermion opens new storage facility at its Hanko plant for handling APIs > 400 mt
Fermion Oy (13th January 2012): In the summer of 2011, Fermion began construction on a new finished product storage area for APIs produced at its plant in Hanko, Finland. This expansion was necessitated by higher than expected API volumes. Construction was completed in November and... Read more
Small-scale facility for compound with high potency
Fermion Oy (13th January 2012): SMALL SCALE HIGH POTENCY FACILITY Fermion’s New Small Scale Production Lab for High Potency API’s. Fermion has been manufacturing the important anticancer drugs Cyclophosphamide, Mercaptopurine and Methotrexate for over 40 years. Fermion continues... Read more
Large-scale facility for manufacturing compounds with high potency
Fermion Oy (13th January 2012): Fermion Opens New High Potency Facility Capable of Handling OEL Class V Compounds Fermion was first inspected by the US FDA in 1979. Since that time Fermion has maintained a strong regulatory track-record and has enjoyed uninterrupted commercial cGMP... Read more
RenaSci's new drug abuse liability service
RenaSci (12th January 2012): RenaSci’s new drug abuse liability service RenaSci has recently expanded its experimental and consultancy services and now offers comprehensive abuse liability assessments, a mandatory regulatory requirement for all centrally-acting drugs. Our... Read more
ICON Selected by Shire plc’s Specialty Pharmaceuticals division as Global Strategic Partner
ICON plc (10th January 2012): 09 January 2012 ICON has signed a strategic partnership with Shire Specialty Pharmaceuticals. ​ ICON today announced that is has signed a strategic partnership with Shire Specialty Pharmaceuticals to serve as the sole global provider of central... Read more
eBESTreports introductory video in YouTube
StatFinn (10th January 2012): eBESTreports are first-in-market reporting engines for drug development. The engines can be used to create full reports with PK calculations and analysis according to regulatory guidelines and with all the appendices in just 24 from the data upload. eBESTreports... Read more
Solid Form Solutions enter into a CO-Promotion agreement with Tillots Pharma AG
Solid Form Solutions Ltd (10th January 2012): Roslin, Scotland/Rheinfelden, Switzerland – 6 January 2012: Solid Form Solutions Limited (“SFS”) and Tillotts Pharma AG (“Tillotts”) announce that they have entered into a co-promotion agreement. SFS a world leading contract research organization... Read more
CROS NT Announces Further Expansion into the UK Market; Andrew MacGarvey Joins Team
CROS NT (9th January 2012): Verona, Italy (9 January 2012) CROS NT is pleased to announce the next phase of its European expansion with the hiring of a new VP and the establishment of a UK office. CROS NT is starting the new year by announcing its expansion into the United Kingdom.... Read more
IBT Bioservices Offers New Mouse Model of Chikungunya Virus Infection
IBT Bioservices (28th December 2011): A powerful new tool is now available to Chikungunya researchers. The AG129 Mouse Model IBT Bioservices has established a lethal model for this disease based on published work by Partidos et al (Vaccine, 2011: 3067-73), that is now available... Read more
Almac publishes Stage II colon cancer recurrence signature in the Journal of Clinical Oncology
Almac (21st December 2011): CRAIGAVON, NORTHERN IRELAND, 07 November 2011 – Almac’s Diagnostics business unit today announced the publication of its stage II colon cancer recurrence signature (diagnostic test) in the Journal of Clinical Oncology. The article entitled “Development... Read more
Almac Invests £1M in Dedicated Mass Spectrometry Laboratory
Almac (21st December 2011): Almac has established a dedicated mass spectrometry laboratory in their European Headquarters, Craigavon, UK. The £1M facility houses state-of-the-art mass spectrometers and underlines Almac’s commitment to providing the best analytical facilities... Read more
Almac Announces Expansion of Pharmaceutical Development Facilities
Almac (21st December 2011): Almac is pleased to announce the expansion of our Pharmaceutical Development services with the creation of a new facility at our UK headquarters in Craigavon. With an initial investment of £4.5million, phase one of the expansion will provide a state-of-the-art,... Read more
ICON Acquires BeijingWits Medical Consulting Ltd
ICON plc (19th December 2011): Acquisition Strengthens ICON’s Presence & Capabilities in China Dublin, Ireland, 12th December, 2011 – ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical... Read more
Sygnature Discovery & Cyprotex Extend Successful Strategic Alliance for a Further 2 Years
Sygnature CSL (16th December 2011): Nottingham and Macclesfield, UK – 16th December 2011 – Sygnature Discovery Ltd., a leading provider of integrated drug discovery services to the pharmaceutical industry, and Cyprotex Discovery Ltd., the world’s largest specialist ADME-Tox/PK pre-clinical... Read more
ICON Acquires BeijingWits Medical Consulting
ICON plc (12th December 2011): 12 December 2011 ICON today announced that it has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting Ltd., a leading CRO in China. The transaction is expected to close in the first quarter of 2012.​ BeijingWits... Read more
Dutch analytical company Abundnz accelerates the development of innovative medicines
Abundnz (8th December 2011): Utrecht, The Netherlands, December 8, 2011. Abundnz B.V. is a new analytical company that offers advanced analytical support to biotech industries developing innovative medicines. Abundnz’s pAMS platform enables first-in-human drug clearance studies in... Read more
Almac’s New Clinical Supply Forecasting Tool – COMPASS – To Improve Clinical Trial Management
Almac (7th December 2011): Almac announces the launch of its revolutionary new forecasting platform, COMPASS, which has been specifically designed to improve the accuracy and efficiency of the supply inventory process during clinical studies. COMPASS provides benefits to clients... Read more
Harrison Clinical Research Group to extend international footprint into Scandinavia
Harrison Clinical Research Ltd (1st December 2011): Munich, Germany 1st December 2011 – Harrison Clinical Research (HCR), an international full service CRO known for its commitment to ‘Outsourcing Dedication’, today announced the extension of the geographic footprint of the combined group into Scandinavia.... Read more
Sygnature Discovery: New Bioscience Group Fully-Operational
Sygnature CSL (21st November 2011): Nottingham, UK – 21st November 2011 – Sygnature Discovery, a leading provider of integrated drug discovery services to the pharmaceutical industry, has today provided an up-date on its new Bioscience group. The team was established in August 2011 and... Read more
AMRI Announces Supply Agreement with Revolymer®
AMRI (9th November 2011): Albany, NY (November 9, 2011)—AMRI (NASDAQ: AMRI), a global contract services organization with services spanning the entire R&D continuum, announced today that it has entered into an agreement with Revolymer®, a technology development company located... Read more
AMRI Announces Third Quarter 2011 Results
AMRI (8th November 2011): Albany, NY (November 8, 2011) — AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30, 2011. Highlights include: • Signed multi-year agreements with Eli Lilly and Company and the National Institutes... Read more
Solvias wins CPhI Exhibitor Sustainability Award in Frankfurt
Solvias AG (7th November 2011): Solvias was announced as the winner of the Exhibitor Sustainability Award at the CPhl Worldwide, ICSE, InnoPack & P-MEC Europe 2011 Exhibitor Party & Innovation Awards Ceremony on October 25th. The integrated chemical and analytical development service... Read more
And the European Outsourcing Award 2011 goes to…Solvias
Solvias AG (7th November 2011): Solvias was announced as the winner of the Exhibitor Sustainability Award at the CPhl Worldwide, ICSE, InnoPack & P-MEC Europe 2011 Exhibitor Party & Innovation Awards Ceremony on October 25th. The integrated chemical and analytical development service... Read more
Dr. Syuzanna R. Harutyunyan wins Solvias Ligand Contest
Solvias AG (7th November 2011): The jury of the annual Solvias Ligand Contest awarded the 2011 prize to Dr. Syuzanna R. Harutyunyan, Assistant Professor in Synthetic Organic Chemistry at the University of Groningen. The Award Ceremony and presentation of the prize-winning contribution... Read more
AMRI Announces Collaboration Agreement with Lilly for In-sourced Chemistry Services
AMRI (7th November 2011): Albany, NY (November 7, 2011) — AMRI (NASDAQ: AMRI) announced today that, as part of a new collaboration agreement with Eli Lilly and Company, it anticipates hiring more than 40 synthetic chemists by the third quarter of 2012 to support Lilly’s drug discovery... Read more
Sygnature Discovery and Saretius Establish Strategic Alliance
Sygnature CSL (31st October 2011): Nottingham and Reading, UK – 31st October 2011 – Sygnature Discovery, a leading provider of integrated drug discovery services to the pharmaceutical industry, and Saretius, a pre-clinical experimental services company offering ‘gold standard’ techniques... Read more
Service providing for microscopy slide digitalisation with Nanozoomer
Histalim (24th October 2011): HISTALIM, the French service provider in histology, offers now a microscopy slide digitalization service both in chromogenic and in fluorescence on the Hamamatsu Nanozoomer 2.0 HT. The progress made in the field of slide digitization now allows users... Read more
Almac Invests in New Commercial API Manufacturing
Almac (24th October 2011): In order to satisfy increasing demands, Almac are expanding their manufacturing capacity to over 30m3 at its European Headquarters in Craigavon, UK. The upgraded facility will include reactor vessels with state of the art clean room product isolation... Read more
Hovione´s Rapid Proof of Concept Dry Powder Inhalation Product Development
Hovione (20th October 2011): Loures, Portugal, 19 October 2011 – Hovione today announced the launch of its Rapid Proof of Concept Study for the development of dry powder inhalation (DPI) products. Building on Hovione´s well established DPI development capability, the new service... Read more
Hovione and Bend Research Enter Into Collaboration To Advance Clients’ Best Medicines
Hovione (20th October 2011): HOVIONE (www.hovione.com), a worldwide pharmaceutical manufacturing firm and BEND, OR – Bend Research Inc. (www.bendresearch.com), a leading independent drug-formulation development company, announced today that they have entered into a nonexclusive,... Read more
Unilabs York Bioanalytical Solutions Opens New Facility on the New Discovery Park in Sandwich, Kent
Unilabs York Bioanalytical Solutions (20th October 2011): As part of Unilabs York Bioanalytical Solutions’ (Unilabs YBS) commitment to providing an unparalleled service to its clients, YBS is pleased to announce the opening of a new facility on the Discovery Park in Sandwich Kent. The new facility will offer... Read more
Selcia and Neurovive to develop New Michochondrial Medicines for Chronic and Acute Diseases
Selcia Ltd (19th October 2011): Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology. Ongar (UK)... Read more
Process Chemistry Conference
DuPont Chemoswed (19th October 2011): Chemoswed to host the 2012 Nordic Process Chemistry Forum. Chemoswed has been nominated to host the biannual process chemistry conference. The event will take place at Arild, near Malmö, on May 23-25 2012. Participating companies will present... Read more
Solvias and RohnerChem announce partnership for custom research and manufacturing services
Solvias AG (12th October 2011): The preferred but non-exclusive partnership closes the chain of services from route scouting through to commercial manufacturing. Customers will benefit from the synergy of Solvias’ expertise in chemical, analytical and solid-state development and RohnerChem’s... Read more
Innovative Analytics Makes Third Consecutive Listing on Inc. Magazine’s 500 | 5000 Top Performing Companies
Innovative Analytics (11th October 2011): October 11, 2011 08:30 ET Innovative Analytics Makes Third Consecutive Listing on Inc. Magazine's 500 | 5000 Top Performing Companies Also Included on Michigan 50 Companies to Watch List KALAMAZOO, MI--(Marketwire - Oct 11, 2011) - While... Read more
ChemCon cleared by Administrative Authority of Tuebingen
ChemCon GmbH (4th October 2011): The Regional Administrative Authority of Tuebingen, Germany inspected ChemCons production plant in Freiburg for the fourth time. The whole Quality Management System was scrutinized by the inspectors with special attention given to vendor qualification,... Read more
First stage complete: Wickham Laboratories acquisition of new facilities has seen a successful development.
Wickham Laboratories Ltd (3rd October 2011): Wickham Labs new facilities at Hoeford point have undergone remodelling to meet their specifications. Modification of the existing 2nd floor purpose built laboratory areas are nearly complete and will soon be ready for the transfer of Pharmaceutical... Read more
CROS NT Group to Sponsor Spanish ePharma Day
CROS NT (29th September 2011): After successful pharma day events in Italy and Germany, the CROS NT Group launches an inaugural conference for the Spanish and Portuguese markets. Verona, Italy (29 September 2011) - The CROS NT Group, comprised of CROS NT and ARITHMOS, is proud to... Read more
Translational assays
MD Biosciences Inflammations Discovery Services (27th September 2011): MD Biosciences is a pre-clinical CRO dedicated to serving the areas of inflammations and neurology. We are currently developing translational assays that utilize human tissue to provide reliable efficacy data prior to Phase II. Read more
ICON Receives Five Finalist Nominations for the 2011 Scrip Awards
ICON plc (27th September 2011): Dublin, Ireland, September 21, 2011 – ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has received five finalist... Read more
Tillotts Services - Meet us at CPhI
Tillotts Services (23rd September 2011): Meet us from October 25 - 27 in Messe Frankfurt, Germany for CPhI Worldwide 2011. Hall 4.1 / Stand 41F67 Read more
Cambridge Major Laboratories Europe successfully undergoes first Regulatory Audit for commercial product
Cambridge Major Laboratories (15th September 2011): Cambridge Major Laboratories Europe (CMLE), a leading supplier of chemistry services supporting drug substance development, has successfully completed its first regulatory pre-approval inspection (PAI) for a commercial API. The audit of the Weert facilities... Read more
Catalent Pharma Solutions Reaches Agreement to Acquire Aptuit LLC's Clinical Trial Supplies Business
Catalent Pharma Solutions (14th September 2011): Catalent to become #2 global clinical trial supply solutions provider, Aptuit to focus on discovery-to-mid phase development business Somerset, NJ and Greenwich, CT – August 22, 2011 — Catalent Pharma Solutions, Inc., and Aptuit, LLC, today announced... Read more
SCM TO UNVEIL FORMULATION SERVICE
SCM Pharma Ltd (13th September 2011): UK-based SCM Pharma is set to officially launch its own formulation development capability after acquiring new facilities as part of a collaborative deal with the University of Sunderland. The development and contract manufacturing organisation (CDMO)... Read more
C3i To Present at the Society for Clinical Data Management (SCDM) Conference in Baltimore, MD
C3i Inc (8th September 2011): C3i, the leader in clinical technology support services for the life sciences industry, will discuss practices to maintain and process information derived from imaging data in oncology during the Society for Clinical Data Management (SCDM) Conference... Read more
Sygnature Chemical Services becomes Sygnature Discovery
Sygnature CSL (5th September 2011): Nottingham, UK – 5th September 2011 – Sygnature Chemical Services, a leading provider of drug discovery services to the pharmaceutical industry, has today become Sygnature Discovery. Due to an unprecedented demand for Sygnature’s services from clients... Read more
Aesica’s QP Service Helps US Clients Reach EU Clinical Trials
Aesica Pharmaceuticals Ltd (31st August 2011): Leading pharmaceutical manufacturer, Aesica, is helping clients to reach EU Clinical Trials through its on-site Qualified Person (QP) service. Aesica has four highly trained and qualified European QP’s at its site in Nottingham, who routinely release... Read more
TGA Sciences, Inc. receives European Medicines Agency certification
TGA Sciences Inc (31st August 2011): City, State/Country - Month Day, Year: Medford, MA- August 31, 2011 Body: TGA Sciences, Inc. has received its certification from the European Medicines Agency (EMA). The CRO is currently FDA registered and inspected, the EMA certification will add... Read more
Unilabs announces global strategic alliance in Companion Diagnostic testing with Biogen Idec for STRATIFY- JCV
Unilabs York Bioanalytical Solutions (24th August 2011): Copenhagen, Denmark, July 6, 2011 –Unilabs has been selected by Biogen Idec to provide a companion diagnostic anti-JCV antibody assay test, called STRATIFY-JCV. The test is a highly sensitive two-step ELISA assay used to detect anti-JCV antibodies. The... Read more
ALLIANCE SELECTS SCM FOR STERILE PRODUCT SUPPLY
SCM Pharma Ltd (23rd August 2011): SPECIALITY pharmaceutical company Alliance Pharma has awarded a commercial supply contract for three of its products to North-East based sterile manufacturing expert SCM Pharma, a development and contract manufacturing organisation (CDMO). SCM Pharma... Read more
ICON Appointment Mario Rocci as President of Early-Phase Division
ICON plc (22nd August 2011): Dublin, Ireland, August 17th 2011 – ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr. Mario Rocci... Read more
CHEMCON does it again: Flawless FDA Inspection
ChemCon GmbH (22nd August 2011): ChemCon´s facility in Freiburg, Germany has been cleared for the production of active pharmaceutical ingredients (APIs) by the US Food & Drug Administration FDA. According to the US regulator, the site is fully compliant with Current Good Manufacturing... Read more
New Biotech Laboratory Expands Selcia’s US Operation
Selcia Ltd (22nd August 2011): Ongar, Essex, United Kingdom (22 August 2011). In response to an ever-growing US client base, Selcia today announced the opening of their new SelciaWest facility, in Hopkinton MA (USA). Simon Saxby, Selcia’s CEO, commented on the opening: “The establishment... Read more
Download Quanticate's White Paper on Flexible Phase I Study Designs: Expediting Early Clinical Drug Development
Quanticate (22nd August 2011): This paper provides an overview of some of the ways in which Phase I packages can be tailored to the needs of the specific compound and conducted more efficiently using combination, flexible protocols. It outlines the considerations that need to be made... Read more
AMRI Receives National Institutes of Health (NIH) Contract Award
AMRI (18th August 2011): AMRI today announced it received a federal contract award from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) to provide chemistry and other drug discovery technologies in support of NINDS’ Medicinal... Read more
Innovative Analytics Dir. CDM, Karen Tindall, instructing DIA’s webinar: Introduction to Clinical Data Management Online
Innovative Analytics (10th August 2011): Title: Introduction to Clinical Data Management Online Training Series Date(s) And Time(s): Sep 13 2011 12:00PM - Sep 22 2011 2:00PM Interest Area(s): Clinical Data Management/ eClinical,Clinical Research,Document Management/ eSubmissions,Professional... Read more
Training Course HPLC-MSMS
AMSlab (1st August 2011): Training course HPLC-MSMS, 20-21 September, Lugo, Spain. Read more
PK/PD Modelling: Reducing Phase III Attrition Rates - Download White Paper
Quanticate (26th July 2011): http://info.quanticate.com/pk-pd-modelling/?utm_campaign=pk%2Fpd-email-shots&utm_source=email Read more
ICON Selected by Pfizer as a Global Strategic Partner for Clinical Research and Development
ICON plc (26th July 2011): ICON Selected For Strength of Services, Quality and Regulatory Compliance and Collaboration Expertise Dublin, Ireland, May 26, 2011 – ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical,... Read more
PharmaNet Names Dr. George Scott Vice President of Bioanalytical Services
PharmaNet Development Group Inc (25th July 2011): Princeton, NJ – July 18, 2011 – PharmaNet Development Group, Inc., an inVentiv Health Company and a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that it... Read more
NiKem Research announces publication of its July newsletter
NiKem Research (20th July 2011): NiKem Research has now published its July Newsletter featuring items on flow chemistry and natural product synthesis, the productivity crisis, phosphoNSAID's, amyloid and tau, locusts in drug discovery, Ifenprodil and NMDA receptors, epigenetics, fluorination... Read more
MBL-European Bioinformatics Institute’s 5th Annual Forum for SMEs – Colleretto Giacosa (Italy) – 6-7 October 2011
Bioindustry Park Silvano Fumero - bioPmed cluster (20th July 2011): MBL-European Bioinformatics Institute’s 5th Annual Forum for SMEs – Colleretto Giacosa (Italy) – 6-7 October 2011   The bioPmed - Piemonte Innovation Cluster on biotech and medtech - is pleased to invite you to the “EMBL - European Bioinformatics... Read more
ICON reports second quarter 2011 net new business of $310 million, revenue of $233 million and EPS of 21c
ICON plc (20th July 2011): Highlights – Second Quarter Fiscal 2011 Net revenue of $233 million, a 4% increase year on year. EPS was 21 cents. Income from operations was $15.5m. Operating margin was 7%. Gross business wins were $357 million representing a gross book... Read more
2011-02-03
Dalton Pharma Services (14th July 2011): Dalton and Oncovir enter into a Manufacturing Services Agreement Toronto, Ontario, February 03, 2011 - Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical companies, today announced the company... Read more
ICON Acquires Firecrest Clinical
ICON plc (14th July 2011): Acquisition Enables ICON to Enhance Investigator Site Performance & Quality Dublin, Ireland, July 14th, 2011 – ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and... Read more
Protagen and VELA form Strategic Partnership
Protagen AG (14th July 2011): Dortmund and Vienna, July 14, 2011. Vela Laboratories, Vienna, one of the leading companies in the area of GMP-compliant potency and release testing of Biopharmaceuticals and Protagen AG, Dortmund, a GMP-certified specialist in the characterization of... Read more
PharmaNet are hosting a complimentary symposium:
PharmaNet Development Group Inc (11th July 2011): PharmaNet are hosting a complimentary symposium: “Rethinking Neuroscience Drug Development” Wednesday, 7 September, 2011 Royal Monceau Raffles, Paris If you are interested in receiving details please email phall@pharmanet.com Read more
PharmaNet are hosting a complimentary Breakfast Symposium:
PharmaNet Development Group Inc (11th July 2011): PharmaNet are hosting a Complimentary Breakfast Symposium “Strategies in Clinical Outsourcing & Risk Management” July 15th, 2011 Hotel Fort Canning, Singapore email if you are interested in attending: phall@pharmanet.com Read more
Simon Hirst: Nottingham Post’s Science & Technology Entrepreneur of the Year Award Winner
Sygnature CSL (8th July 2011): Nottingham, UK – 8th July 2011 - Dr Simon Hirst, Sygnature’s Founder and CEO, was the well-deserved winner of the prestigious Nottingham Post’s Science & Technology Entrepreneur of the Year Award. The Awards Presentation Dinner was held at the Council... Read more
SCM APPOINTS NEW DIRECTOR
SCM Pharma Ltd (4th July 2011): STERILE filling specialist SCM Pharma has taken on a highly experienced non-executive director as the UK-based company bolsters its senior team to support its strategic development. Adam Sims joins the board at the contract manufacturing organisation... Read more
Spedia-NMR™: Breakthrough in Bioprocess Optimization For Biologicals
Spinnovation Analytical BV (4th July 2011): 4th July 2011: Spinnovation, Nijmegen, The Netherlands. For new biologicals and biosimilars, the innovative Spedia-NMR™ technology from Spinnovation Biologics provides a real advantage for optimizing cell cultures , monitoring and standardizing manufacturing... Read more
Enzyme catalysed access to chiral API key building blocks
Pharmatory Ltd (30th June 2011): Pharmatory Ltd is a contract manufacturer of APIs for preclinical and Phase I and II studies as well as low volume market compounds. We are now able to provide enzyme catalysed resolution of secondary alcohols, resolution and stereoselective synthesis... Read more
Dr. Joel Posener Joins PharmaNet as Executive Medical Director, Neuroscience
PharmaNet Development Group Inc (29th June 2011): Princeton, NJ – June 29, 2011 – PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that Joel Posener, MD, has joined the Company... Read more
MEMORANDUM OF UNDERSTANDING SIGNING CEREMONY PITDC, PHARMANET AND PEI LI PHARMACEUTICAL
PharmaNet Development Group Inc (28th June 2011): On 27 June 2011, a signing ceremony for a Memorandum of Understanding (MOU) will be held in Washington, DC, during the 2011 BIO International Convention between Pharmaceutical Industrial Technology Development Center (PITDC), a Taiwan-based institute... Read more
Vantage BioTrials President named as the only CRO executive for the "2011 Emerging Pharma Leader" recognition by Pharma
Vantage Biotrials (28th June 2011): Vatche Bartekian, President of Vantage BioTrials has been chosen amongst 30 highly profiled individuals as one of the Emerging Pharma Leaders of 2011: http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=726109&sk=&date=&pageID=6 As... Read more
iNovacia Further Develops its Compound Collection
iNovacia AB (28th June 2011): iNovacia, the drug discovery service provider and subsidiary of Kancera AB (Nasdaq OMX Stockholm First North, KAN), today announced the addition of over 20,000 novel compounds to its small-molecule screening collection. This is in line with the continuous... Read more
Cambridge Major Laboratories Europe Selected to Support Summit’s “Superbug Antibiotic” Clostridium Difficle Programme
Cambridge Major Laboratories (27th June 2011): Weert, The Netherlands (June 27th 2011) – Cambridge Major Laboratories Europe (CMLE), a leading supplier of chemistry services supporting drug substance development, has been selected by Summit Corporation plc (Summit) to provide process chemistry services,... Read more
Surmount Clinical Research Services-Achieving Heights in Clinical Research
Surmount Clinical Research services (26th June 2011): Surmount Clinical Research Services is an upcoming Site Management Organization in Ahmedabad, India which believes in providing excellent clinical research services according to the highest quality, professional, ethical and scientific standards. Integrated... Read more
VTU Technology Launches Breakthrough Technology for High Level Methanol-free Protein Expression in Pichia pastoris
VTU Technology (23rd June 2011): VTU Technology, a leading contract research and development company providing services for the fast-track generation of high-performance industrial protein expression strains and processes for the biopharmaceutical and other protein industries is pleased... Read more
Hong Kong-based Asia Pacific Clinical Research and Audit (APCRA) a new independent contract research organization (CRO),
APCRA (22nd June 2011): The organization was formed from a joint venture between 4med future AB and Asia Pacific Clinical Research Auditors. Speaking at the official launch CEO, Helena Hagelberg said:”the joint venture between the two organizations will enable clients in Europe... Read more
Hong Kong-based Asia Pacific Clinical Research and Audit (APCRA) a new independent contract research organization (CRO),
APCRA (22nd June 2011): The organization was formed from a joint venture between 4med future AB and Asia Pacific Clinical Research Auditors. Speaking at the official launch CEO, Helena Hagelberg said:”the joint venture between the two organizations will enable clients in Europe... Read more
Gamlen Tableting release new video of the Gamlen Tablet Press
Gamlen Tableting Ltd (22nd June 2011): The Gamlen Tablet Press is the worlds only computer controlled, bench top tablet press. We are pleased to announce that you can now see it on YouTube.... at http://youtu.be/BjdfOt48N3c We hope you enjoy the video. Read more
Quotient announces new RapidFACT program with MediGene
Quotient Clinical (21st June 2011): Quotient Clinical, a business unit of Quotient Bioresearch (Quotient), today announced an agreement with MediGene AG (MediGene), the German biotechnology company, to undertake a RapidFACT formulation development and clinical testing program on RhuDex,... Read more
Workshop on Translating Science into Business
VAC3 Clinical Services (21st June 2011): This October, Xcell BioConsulting, a leading Bio-Consulting firm in South Africa, with marketing partner, VAC3 Clinical Services, India is organizing Workshop on "Translating Science into Business" in Bengaluru and Mumbai on 1st and 8th October 2011 respectively. Please... Read more
IBT Bioservices to Exhibit at BIO 2011 in Washington, DC
IBT Bioservices (21st June 2011): Key staff from IBT Bioservices will be on hand to exchange information with any and all interested parties at BIO's 2011 International Conference next week in Washington, DC. The table can be found in Booth 3504, the Maryland pavilion. The team sincerely... Read more
Harrison Clinical Research acquires Global IQ to further extend international footprint
Harrison Clinical Research Ltd (20th June 2011): Munich, Germany & Edmonton, Canada June 20th 2011 – Harrison Clinical Research (HCR), an international full service CRO known for its commitment to ‘Outsourcing Dedication’, today announced the acquisition of Global IQ to extend the geographic footprint... Read more
ICON Announces ICONIK – An Integrated Technology Solution Providing a Single View of Study Information
ICON plc (20th June 2011): Solution Incorporates First CRO Deployment of Oracle Life Sciences Data Hub Dublin, Ireland, June 20th, 2011 – ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and... Read more
New features at Chemonaut, the advanced compound sourcing platform
Chemonaut (15th June 2011): The online compound sourcing application of Chemonaut has been upgraded with new features and improvements, which further increase the efficiency of compound selection and procurement processes. The most important improvement of the new version is... Read more
The World Health Organization Grants Pre-qualified Status to Second SGS Facility: SGS Life Science Services Belgium
SGS Life Sciences (15th June 2011): SGS Life Science Services is pleased to announce that its facility in Wavre, Belgium has achieved prequalified status from the World Health Organization (WHO) effective May 31, 2011. WHO prequalification demonstrates that a laboratory has met established... Read more
EDETEK, Inc. granted CDISC Registered Solution Provider status
Edetek (14th June 2011): EDETEK, Inc. has joined a select group of just 16 other companies worldwide to receive the coveted Registered Solution Provider designation from the Clinical Data Interchange Standards Consortium (CDISC). Princeton, NJ – June 13, 2011 – EDETEK, Inc.,... Read more
Wickham Laboratories Announce New Facilities:Hampshire Company Expands at new site.
Wickham Laboratories Ltd (10th June 2011): Wickham Laboratories Limited (WLL) are pleased to announce their acquisition of new facilities in Hampshire. WLL have completed the purchase of the former Wyeth facilities in Barwell Lane Gosport. The site will be known as Hoeford Point and is on the... Read more
C3i Inc to Provide Full-Service Technology Support and Oracle Clinical, Oracle Remote Data Capture Business Process Outs
C3i Inc (3rd June 2011): C3i, a world leader in clinical trial support services, today announced the signing of its newest client, XBiotech, Inc. XBiotech, located in Austin, TX, is a leader in the development of therapeutic antibodies, and has launched the first “True Human”... Read more
The exhibitions list that SINOPEP will attend in 2011
Sinopep Pharmaceutical Inc (2nd June 2011): Welcome to visit our booths in the following exhibitions: (1) CPhI Shanghai. June 21-23, 2011. Booth No.:W2E42 (2) 2011 BIO INTERNATIONAL CONVENTION. June 27-30, 2011. Washington, D.C. Booth No.:2060 (3) CPhI South America. Aug 24-26,... Read more
Meet ChemCon at Bio 2011 in Washington (Germany Pavilion)
ChemCon GmbH (1st June 2011): Once again, ChemCon is going to meet international customers during BIO International Convention 2011 in Washington. Meet us at the German Pavilion ( boot 2227 ) or contact us by email to schedule an appointment: reinhard.hirsch@chemcon.com Read more
Ubichem Research acquisition to enable further growth of Pharma Services business
Ubichem plc (31st May 2011): The majority share of Ubichem Research Ltd, a leading provider of chemistry services to the drug development sector, through Ubichem Pharma Services, has been acquired by financial investment company Lochlomond Holding Limited, owned by Marton Szoke,... Read more
SGS Announces Investment in New Life Science Services Facility in Mumbai, India
SGS Life Sciences (31st May 2011): SGS, the world’s leading inspection, verification, testing and certification company, announced today its plan to open a second Life Science Services facility in India. This announcement comes during Interphex Asia, a major trade conference for service... Read more
Looking for Pulmonary Hypertesion in vivo models?
Syncrosome (26th May 2011): http://www.syncrosome.com/blog/ Read more
CMO SET TO MANUFACTURE CANCER PRODUCT
SCM Pharma Ltd (26th May 2011): SPECIALITY European Pharma (SEP) has initiated the transfer of the commercial supply of its oncology product Plenaxis® to contract manufacturing organisation (CMO) SCM Pharma. The initial Manufacturing Development Agreement between the two firms covers... Read more
LOGOS TECHNOLOGIES JOINS MEDIDATA SOLUTIONS TECHNOLOGY PARTNER PROGRAM
Logos Technologies Ltd (20th May 2011): Interoperability Partnership Enables Seamless Flow of Data Between Logos Technologies ALPHADAS Early Phase Solution and Rave EDC/CDM System NEW YORK, N.Y. – May 20, 2011 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based... Read more
Theradex attends BioWashington 2011
Theradex Ltd (17th May 2011): If you wish to discuss any aspect of your oncology clinical trials at this meeting, please do not hesitate to send me a invite through the partnering system or directly though the enquiry procedure on this (Bio2Business) website. Read more
READ MORE ABOUT INNOVATIVE ANALYTICS HONORED AS ONE OF 2011'S "MICHIGAN 50 COMPANIES TO WATCH": http://marketwire.com/C
Innovative Analytics (17th May 2011): FOR IMMEDIATE RELEASE April 1, 2011 Contact: James Dancy Co-founder Innovative Analytics, Inc. 161 East Michigan Avenue, Suite 5 Kalamazoo, MI 49007 269.377.2599 jmdancy@ianalytics.biz Contact: Ron Kitchens Chief Executive... Read more
Curemark Reports Positive Results for Novel Compound CM-182 In Schizophrenia Mouse Model
Cerca Insights (13th May 2011): April 2011 RYE, New York, April 25, 2011 - Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that its compound CM-182 demonstrated positive results for schizophrenia in the transgenic... Read more
Screening compound resynthesis services from Chemonaut and iThemba Pharmaceuticals
Chemonaut (11th May 2011): iThemba Pharmaceuticals and Chemonaut announce a collaboration on providing a screening compound re-synthesis service. The collaboration has stemmed from both companies recognising that in the dynamically changing world of screening compound supply, it... Read more
SCM SECURES PHASE II ASEPTIC PROJECT
SCM Pharma Ltd (5th May 2011): CLINICAL trial manufacturer SCM Pharma has secured a sterile filling and packaging project with Molteni Therapeutics, an Italian-based specialty pharmaceutical company, which involves a novel drug substance being developed for the topical treatment of... Read more
Quotient Clinical expands clinical capacity in response to customer adoption of its Synthesis-to-Clinic human ADME servi
Quotient Clinical (5th May 2011): Quotient Clinical, a business unit of Quotient Bioresearch(“Quotient”), today announced the completion of a major expansion of its clinical facilities in Nottingham, UK. Bed capacity has been increased by 50 per cent and a dedicated sample processing... Read more
AKESOgen at BIO 2011 International Convention in Washington DC, June 27-30, 2011
AKESOgen Inc (4th May 2011): AKESOgen to attend the BIO 2011 International Convention in Washington DC in June 27-30, 2011. To schedule a private meeting with AKESOgen representatives please email info@akesogen.com. A delegate will contact you to set up a meeting. Look forward to... Read more
ICON and ACRONET Sign Alliance Agreement in Japan
ICON plc (21st April 2011): Alliance Strengthens Geographic Coverage for both CROs Dublin, Ireland, April 21, 2011 ICON plc and ACRONET Corporation, one of Japan’s largest CROs, today announced they have signed an alliance agreement. Through the agreement, ICON and ACRONET will... Read more
ICON Continues Asia-Pacific Expansion with New Office Opening in Shanghai and Senior Appointments in the Region
ICON plc (21st April 2011): Dublin, Ireland, March 29th, 2011 ICON plc NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced its ongoing expansion in Asia-Pacific.... Read more
ICON Reports first quarter 2011 revenue up 5% to $229 million and EPS of 21c
ICON plc (21st April 2011): Highlights – First Quarter Fiscal 2011 Net revenue of $229 million, a 5% increase year on year, 6% at constant currency. Income from operations was $16m, before restructuring charges. Operating margin before the restructuring charges was 7% and... Read more
IBT To Attend 24th ICAR in Sophia, Bulgaria
IBT Bioservices (20th April 2011): IBT Bioservices will be presenting data at the 24th International Conference on Antiviral Research. The event will take place at Kempinski Hotel Zografski from May 8th through May 11th. More on the event at their website: http://isar.phrm.cf.ac.uk/node/78 If... Read more
Crystallics spins out of Avantium Holding
Crystallics BV (19th April 2011): Crystallics – a new company with a long history in pharmaceutical development Amsterdam, The Netherlands, 19 April 2011 – Avantium Pharma BV, a leader in solid state research and pre-formulation for the pharmaceutical industry over the last 11 years,... Read more
EganLee- Trial Focus Completes First Contract
EganLee Australia Pty Ltd (13th April 2011): EganLee – Trial Focus has completed the work first contract won since the company’s recent inception in late 2010. The directors, Vicky Wong and Yvonne Egan Davidson each have around 20 years experience in clinical trials in Australia and Asia Pacific... Read more
Spinnovation launch new biologics division with unique service provision
Spinnovation Analytical BV (7th April 2011): NEWS RELEASE Spinnovation launch new biologics division with unique service provision 7 April 2011: Spinnovation, Nijmegen, The Netherlands: On 7 April 2011, Frederic Girard, CEO of integrated NMR specialists, Spinnovation Analytical BV (Nijmegen,... Read more
C3i Opens Asia Operations Center in Dalian, China
C3i Inc (7th April 2011): Morristown, NJ – 7 April 2011– C3i, the global leader in technology support and BPO services for the pharmaceutical industry, announced today the opening of its new Global Operations Center in China. The operations center, located in the northern city... Read more
ACM Global Expands to New Facility - US specimen processing department moves to cater for growth in clinical trials
ACM Global Laboratories (3rd March 2011): Rochester, NY, Mar 2. 2011 – ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, today announced the specimen processing department at its US site, located in Rochester,... Read more
Selcia and ExonHit Therapeutics Announce Successful Fragment Screening Collaboration
Selcia Ltd (28th February 2011): Ongar, Essex (United Kingdom) - 28 February 2011. Selcia Ltd today announced the successful completion of a drug discovery project with ExonHit Therapeutics SA (Paris, France), using Selcia’s fragment screening technology. Novel and weak affinity hits... Read more
CMO GEARS-UP FOR U.S. DEMAND WITH POTENT EXPANSION
SCM Pharma Ltd (24th February 2011): STERILE manufacturing expert SCM Pharma has announced details of its expanded potent capacity following a major £500,000k investment at its UK-based facility. The specialist contract manufacturing organisation (CMO) will use Interphex Exhibition... Read more
Selcia appoints Simon Saxby as CEO and Andreas Rummelt to its Board
Selcia Ltd (22nd February 2011): Ongar, Essex (United Kingdom)- 22February 2011. Selcia, a leading provider of contract research services, today appointed Simon Saxby as its Chief Executive Officer (CEO). He will assume his position in April and takes over from Dr Hans Fliri who retains... Read more
AXIS Clinicals announces successful completion of Sixth US FDA Audit
AXIS Clinicals Ltd (16th February 2011): Hyderabad, INDIA – AXIS Clinicals Limited, India’s Premier Clinical Research Organization (CRO), announces today that it has successfully completed its 6th US FDA Audit with out 483s. AXIS Clinicals successful audits confirmed that the company's quality... Read more
PROSTRAKAN SELECTS CMO FOR SUPPLY OF NETHERLANDS PRODUCT
SCM Pharma Ltd (3rd February 2011): International specialty pharmaceutical company, ProStrakan Group plc, has awarded SCM Pharma (www.scm-pharma.com) a five-year contract for the ongoing supply of its licensed product, Ketensin.   The UK-based contract manufacturing organisation (CMO)... Read more
AXIS Clinicals Obtains ISO 9001:2008 Accreditation
AXIS Clinicals Ltd (3rd February 2011): Hyderabad, INDIA, February 03, 2011 – AXIS Clinicals announced today that AXIS Clinicals has obtained ISO (International Organization for Standardization) 9001:2008 accreditation from Bureau Veritas. This accreditation is an international standard for... Read more
Early Decision Making in Clinical Development - Quanticate Complimentary Networking Event - 16th Feb 2011, London, UK
Quanticate (2nd February 2011): Attend our February Networking Event to learn more on early decision making in clinical development. Our expert speaker panel will look at the concept of smarter study designs that compress timelines and costs in early clinical development. Event... Read more
ACM Global Central Laboratory Appoints Head of Project Management, Asia Pacific
ACM Global Laboratories (25th January 2011): ACM Global Central Lab, the global central laboratory that continually defines the customer-service standard with its flexible approach, today announced the newest member of its Clinical Trials team, Sonal Deshmukh, as the Head of Project Management Asia... Read more
Encap Drug Delivery FDA Inspection
Encap Drug Delivery (25th January 2011): Encap Drug Delivery was inspected by the US FDA from 13-17th Sep 2010. The inspection was a full six system GMP inspection covering the Quality System, Facilities and Equipment, Materials Management, Production, Packaging and Labelling, and Laboratories.... Read more
Solvias opens new Corporate Location
Solvias AG (17th January 2011): On February 2, 2011, Solvias' new office and laboratory building is officially opened. The company, which provides scientific and technical services, has already moved into the new building. Just in time for the New Year, the company relocated from... Read more
New Headquarters for OriBase Pharma
Nova Decision (14th January 2011): Montpellier, Jan 10th 2011 – The French-based company OriBase Pharma has moved into new Headquarters in Biopôle, Montpellier, located in Parc Euromédecine. These facilities provide OriBase Pharma with a new and spacious medicinal chemistry laboratory,... Read more
Solid Form Solutions look forward to welcoming you on Stand 631 at Informex NC
Solid Form Solutions Ltd (12th January 2011): Meet our technical experts and discuss your solid form screening needs. Whisky tasting on the 8th and 9th of Feb from 2pm contact juliescott@solidformsolutions.co.uk to shedule your meeting. See you there ! Read more
2011-01-11
IDT Australia Ltd (10th January 2011): IDT has a new 'state of the art'Penem manufacturing facility available for use. There is API manufacturing up to 300 kg batch size, a commercial scale tablet suite and a sterile suite with vial filling and lyophilisation equipment. Read more
AXIS Clinicals receives ANVISA Certification
AXIS Clinicals Ltd (3rd January 2011): Hyderabad, INDIA, January 03, 2011 – AXIS Clinicals, Fastest Growing Clinical Research Organization (CRO), has received the ANVISA Certification without any findings. “Achieving and maintaining the Brazil ANVISA certification needs continuous improvement... Read more
ACM Global Central Lab makes key appointments at US facility
ACM Global Laboratories (14th December 2010): Rochester, NY, December 13, 2010 – ACM Global Central Lab, the central laboratory that continually defines the customer-service standard with its flexible approach, has announced several key appointments at its US site across administration, lab, operations,... Read more
MedPharm completes License Agreement with Sinclair Pharma for Terbinafine MedSpray®
MedPharm Ltd (7th December 2010): MedPharm Limited, the specialist pharmaceutical development company, is pleased to announce the signing of a licence to Sinclair Pharma Plc for the worldwide rights to develop a patented new spray presentation of the generic anti-fungal, terbinafine,... Read more
MEDPHARM ISSUED NEW PATENT IN CHINA FOR MEDSPRAY®
MedPharm Ltd (30th November 2010): Patent introduces stepping stone for specialist topical company into Chinese and Asian markets MedPharm Limited (www.medpharm.co.uk), a specialist pharmaceutical development company which is recognized internationally for its expertise in topical drug... Read more
Convergence Pharmaceuticals and Selcia Announce Drug Discovery Collaboration Around Chronic Pain
Selcia Ltd (22nd November 2010): Cambridge and Ongar, UK; 22 November 2010: Convergence Pharmaceuticals Limited (“Convergence”), the new company focused on the development of novel and high value analgesic medicines, and Selcia Limited (“Selcia”), a contract research organisation, today... Read more
PII ASEPTIC FACILITY RECEIVES FIRST FDA INSPECTION
Pharmaceutics International Inc (PII) (11th November 2010): Hunt Valley, Maryland ‐ November 11, 2010 ‐ Pharmaceutics International, Inc (Pii), a leading provider of pharmaceutical contract manufacturing services, today announced that the company’s aseptic manufacturing facility in Hunt Valley, Maryland... Read more
QED Launches Innovative Re-Designed Website Targeted at Biotech Sponsors
QED Clinical Services Ltd (9th November 2010): As part of QED’s continued Business Development and Marketing efforts, we are pleased to announce a major re-design to our website to provide more comprehensive information on our background, experience and capabilities for current and potential Biotech... Read more
Maccine Opens Preclinical MRI Suite
Maccine Pte Ltd (3rd November 2010): Singapore, Maccine extended a leading position in translational imaging research this week as the Singaporean contract research firm announced the opening of a dedicated non-human primate (NHP) magnetic resonance imaging (MRI) centre. This features alongside... Read more
Prof. Jaesook Yun wins Solvias Ligand Contest
Solvias AG (28th October 2010): In recognition of her contributions in the area of asymmetric catalysis and the application of Solvias ligands, Solvias awarded the 2010 prize to Professor Jaesook Yun from the Department of Chemistry, Sungkyunkwan University, Korea. Ligand_contest Solvias... Read more
SCM SET FOR JAPANESE MISSION
SCM Pharma Ltd (26th October 2010): A UK-based sterile contract manufacturing organisation (CMO) specialist is set to fly the flag for the region’s manufacturing sector after being selected for a high-profile international trade mission.   Drug manufacturer SCM Pharma is one of only 20... Read more
Community Research selects ALPHADAS®, Logos Technologies Early Phase EDC System
Logos Technologies Ltd (18th October 2010): It is announced today that Community Research has entered into an agreement with Logos Technologies’ for its’ market leading, early phase, e-source data capture system and site automation software suite, ALPHADAS which gives clinical research sites unsurpassed... Read more
Community Research selects ALPHADAS®, Logos Technologies Early Phase EDC System
Logos Technologies Ltd (18th October 2010): It is announced today that Community Research has entered into an agreement with Logos Technologies’ for its’ market leading, early phase, e-source data capture system and site automation software suite, ALPHADAS which gives clinical research sites unsurpassed... Read more
Richmond Pharmacology selects ALPHADAS®, Logos Technologies Early Phase EDC System
Logos Technologies Ltd (15th October 2010): It is announced today that Richmond Pharmacology has selected the market leading, early phase, e-source data capture system and site automation software suite ALPHADAS which gives clinical research sites unsurpassed tools to accelerate and streamline... Read more
Richmond Pharmacology selects ALPHADAS®, Logos Technologies Early Phase EDC System
Logos Technologies Ltd (15th October 2010): It is announced today that Richmond Pharmacology has selected the market leading, early phase, e-source data capture system and site automation software suite ALPHADAS which gives clinical research sites unsurpassed tools to accelerate and streamline... Read more
Fundación de Investigación de Diego selects ALPHADAS®, Logos Technologies Early Phase EDC System
Logos Technologies Ltd (12th October 2010): It is announced today that Fundación de Investigación de Diego, Puerto Rico’s premier clinical research site, has purchased ALPHADAS®, Logos Technologies Inc’s early phase, e-source data capture system and site automation tools to accelerate and streamline... Read more
Fundación de Investigación de Diego selects ALPHADAS®, Logos Technologies Early Phase EDC System
Logos Technologies Ltd (12th October 2010): It is announced today that Fundación de Investigación de Diego, Puerto Rico’s premier clinical research site, has purchased ALPHADAS®, Logos Technologies Inc’s early phase, e-source data capture system and site automation tools to accelerate and streamline... Read more
Cerbios Pharma successfully passes a general FDA GMP inspection
Cerbios (11th October 2010): It is with pleasure that we announce that on Thursday evening, September 30th 2010, Cerbios-Pharma SA successfully passed a general FDA GMP inspection. Originally, the inspection was scheduled to last four days with two inspectors. Due to the excellent... Read more
Recipharm AB acquires Abbott Manufacturing Site in Spain
Recipharm (1st October 2010): Acquisition set to enhance Recipharm’s presence in Southern Europe Recipharm AB (Stockholm) announces today that they have acquired Abbott’s (formerly Solvay Pharmaceuticals) manufacturing site in Parets, close to Barcelona, Spain for an undisclosed... Read more
Nova Decision & Azasynth to Merge, Creating OriBase Pharma
Nova Decision (27th September 2010): Montpellier, September 27th 2010 - Nova Decision and Azasynth announced today a definitive merger agreement to create OriBase Pharma. The new company will offer the pharmaceutical and biotech industries’ most complete set of drug discovery products and... Read more
Orla and NPL secure TSB funding to improve TB detection methods
Orla Protein Technologies (27th September 2010): Two UK companies have been awarded joint funding for a research project that could see significant advances in the quest to aid detection and eradication of Tuberculosis (TB), across the world. The National Physical Laboratory (NPL) and Orla Protein... Read more
AEPODIA SA to join Leading Chief Scientific Officers at the Evolution Summit, hosted by marcus evans Summits
Aepodia SA (23rd September 2010): marcus evans summits, is pleased to announce AEPODIA SA as a Sponsor at the Evolution Summit, taking place 27-29 October 2010 at the prestigious Fairmont Le Montreux Palace, Montreux, Switzerland. AEPODIA SA, an independent consultancy company specialised... Read more
Novasep appoints a new Chairman for its Supervisory Board - Bernard Dubois, former Aventis Senior VP of Global Industria
Novasep (1st September 2010): Pompey, France, September 1, 2010 – Novasep, a leading supplier of manufacturing solutions to the life science industries, announces the appointment of Bernard Dubois as Chairman of its supervisory board. Bernard Dubois replaces Pietro Stefanutti, who... Read more
SANOFI CALLS ON CMO FOR REPEAT C14 PROJECT
SCM Pharma Ltd (31st August 2010): FRENCH pharmaceutical company sanofi-aventis has once again selected contract manufacturing organisation (CMO) SCM Pharma for the fast-tracked fill/finish of a radio-labelled product. Just a year after appointing the UK-based specialist manufacturer... Read more
RecipharmCobra Biologics Announces Patent for Novel Antibiotic-Free Plasmid Maintenance System
Recipharm (31st August 2010): oriSELECT system wins US and European patents RecipharmCobra Biologics, the international manufacturer of biopharmaceuticals, today announces that it has been granted European and United States patents for its novel plasmid maintenance system.... Read more
Biotec launches specialist primary packing service
Biotec Services International Ltd (24th August 2010): UK-based pharmaceutical services company, Biotec Services International Ltd, has introduced a new MHRA approved primary packing service to meet growing demands from pharmaceutical and biotech companies worldwide. The new primary packing suite will... Read more
Melbourn Scientific offers faster formulation for product development
Melbourn Scientific (18th August 2010): See Melbourn Scientific at ICSE 2010 Hall 4, Stand 4F110 A new fast formulation screening service, that will accelerate the development of formulations where poor bioavailability is an issue, is to be announced by Melbourn Scientific at ICSE. The... Read more
SANOFI CALLS ON CMO FOR REPEAT C14 PROJECT
SCM Pharma Ltd (9th August 2010): FRENCH pharmaceutical company sanofi-aventis has once again selected contract manufacturing organisation (CMO) SCM Pharma for the fast-tracked fill/finish of a radio-labelled product. Just a year after appointing the UK-based specialist manufacturer... Read more
CMO UNVEILS TESTING SERVICES
SCM Pharma Ltd (4th August 2010): FILL/FINISH specialist SCM Pharma has launched two new testing services to complement its sterile manufacturing capabilities and reduce the risks associated with offsite testing for client projects.   The UK-based contract manufacturing organisation... Read more
Single Crystal X-Ray Determination Partnership
Park Place Research Ltd (28th July 2010): UK pharmaceutical process research and development specialist Park Place Research and Cambridge University X-ray department (Dr John Davies) are pleased to announce a collaboration, for single crystal structural determination. Park Place Research... Read more
Cerenis Therapeutics and Novasep awarded EUR 10.7 million funding from the French Government for the development CER-001
Novasep (26th July 2010): July 26, 2010 - Toulouse and Pompey, France: Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and other metabolic diseases, and Groupe Novasep (Novasep), a... Read more
UK CMO SECURES NEW BUSINESS
SCM Pharma Ltd (20th July 2010): FILL/FINISH specialist SCM Pharma has picked up several new and repeat contracts that will initially be worth around £500k, including its first US-based client. The projects, which cover the manufacturing and supply of drug products for clinical trials... Read more
Biotec invest in ultra low temperature storage
Biotec Services International Ltd (15th July 2010): Leading UK-based pharmaceutical services company, Biotec Services International, has expanded its ultra low temperature storage capacity to accommodate growing demand for the long term storage of biopharmaceuticals. The 300% increase in ultra low storage... Read more
NEW RESEARCH COLLABORATION TO ADVANCE STEM CELL USE
Orla Protein Technologies (15th July 2010): A new collaborative research project has secured a government investment of £200,000 to develop technology which could pave the way for dramatic advances in life science research. North East-based Orla Protein Technologies Ltd, The UK Stem Cell Bank... Read more
Orla, UK Stem Cell Bank & Newcastle University secure TSB grant for stem cell project
Orla Protein Technologies (13th July 2010): A new collaborative research project has secured a government investment of £200,000 to develop technology which could pave the way for dramatic advances in life science research. North East-based Orla Protein Technologies Ltd, The UK Stem Cell Bank... Read more
Press Release - Solvias invites you to the 9th Solvias Science Day
Solvias AG (7th July 2010): With the upcoming event, the science and technology service company will be adding extra strings to its bow far beyond chemical development and catalysis and will for the first time be offering a series of lectures on solid-state development and on the... Read more
Veeda Oncology Announces $8.4 million in New Business
Veeda clinical research (29th June 2010): Veeda Oncology®, a full service Oncology CRO with facilities in North America, Europe and India, has been awarded over $8.4 million of new clinical research programs over the past 30 days. The awarded work will be conducted in India, Europe and the... Read more
Simon Saxby Joins Board at Selcia
Selcia Ltd (29th June 2010): Ongar, Essex, United Kingdom (28 June 2010). Selcia Limited, a leading provider of contract research services in 14-C custom radiolabelling, integrated drug discovery, fragment screening and medicinal chemistry today announced the high profile appointment... Read more
Solvias AG announces agreement for the manufacturing of the active pharmaceutical ingredient (API) for Rottapharm|Madaus's phase I candidate, CR4056.
Solvias AG (18th June 2010): Rottapharm | Madaus is developing CR 4056 for the treatment of neuropathic pain and acute non-specific pain states. CR 4056 is a novel imidazoline (I2) ligand endowed with potent analgesic activities demonstrated in different animal models related to... Read more
Invitation to the 9th Solvias Science Day
Solvias AG (8th June 2010): New Trends, Strategies and Technologies in Research & Development Date: Monday, October 25th, 2010 Place: Congress Center Basel, Switzerland Time: 8:50 a.m. - 5 p.m. Fee: Free of charge Program Description: The program will feature contributions... Read more
DUTCH DRUG DEVELOPMENT CLUSTER
Cambridge Major Laboratories (2nd June 2010): CML Europe is a founder member of the Dutch Drug Development Cluster, a group of companies who have come together to align service offerings to the biotech/emerging pharma sector. All globally recognised in their respective fields, AVANTIUM PHARMA, SYNCOM,... Read more
Ubichem approved for cGMP radiolabelled API production
Ubichem plc (2nd June 2010): Ubichem, a leading provider of chemistry services to the drug development sector, through its Hungarian operation – Ubichem Research - has successfully completed a regulatory inspection and is now approved for the supply of cGMP radiolabelled Active Pharmaceutical... Read more
'Partner with experience' Melbourn Scientific advises at ERBI
Melbourn Scientific (20th May 2010): Are Biotech companies missing out on cost-saving wisdom? For biotech companies who want to extend their cash runways in the face of funding shortfalls, working with a well established, highly regulated partner could enable delivery milestones to be... Read more
SCM Delivers For University Of Oxford
SCM Pharma Ltd (5th May 2010): FILL/FINISH specialist SCM Pharma (www.scm-pharma.com) has successfully completed a fast-tracked aseptic processing project for internationally-famous academic institution, the University of Oxford. The project team at the university’s Clinical Biomanufacturing... Read more
Chemoswed extends analytical capabilities and upgrades kilolab facilities
DuPont Chemoswed (28th April 2010): We continue to update and extend our capabilities by adding techniques and instruments which enhance our ability to accomodate customer needs. The growing number of transition metal-assisted transformations applied within API manufacture, and an ever... Read more
Asterand Sponsors Inaugural Human Tissue Research Conference
Asterand plc (23rd April 2010): Asterand Sponsors Inaugural Human Tissue Conference Opinion Leaders share insights on human tissue models, cancer research and drug discovery Asterand plc (LSE: ATD), a leading global supplier of human tissue and human tissue-based research services... Read more
Asterand and Ono initiate multi-year drug discovery collaboration
Asterand plc (23rd April 2010): ASTERAND’S SUBSIDIARY BIOSEEK AND ONO INITIATE NEW MULTI-YEAR DRUG DISCOVERY COLLABORATION SOUTH SAN FRANCISCO, CA, USA and OSAKA, JAPAN – March 22, 2010 – BioSeek, LLC,a subsidiary of Asterand plc (LSE: ATD), a pioneer in the application of predictive... Read more
Asterand accepted into Good Laboratory Practice (GLP) Compliance Program
Asterand plc (23rd April 2010): Asterand’s UK Facility Accepted into Good Laboratory Practice (GLP) Compliance Monitoring Programme The Company Extends its Service Offering into the Preclinical Development Market Asterand plc (LSE: ATD), a leading provider of human tissue and... Read more
Lab Research Announces Its 2009 Financial Results
Lab Scantox (31st March 2010): Quarterly backlog improvement of 31.4% 54% jump in request for quotations and new services launched to drive double-digit revenue growth in local currencies in the first quarter of 2010. LAVAL, QC, March 31, 2010 - LAB Research Inc. ("LAB Research"... Read more
MELBOURN SCIENTIFIC APPLIES MORPHOLOGI G3 TO PRE-FORMULATION
Melbourn Scientific (11th March 2010): Melbourn first to offer Malvern’s award wining image processing technology As part of an extension to its product development capabilities, Melbourn Scientific has become the first contract research organisation in Europe to invest in the award winning... Read more
Provepharm announces acceptance of Proveblue® injectable drug MAA for review under EMEA centralized procedure and valida
Novasep (11th February 2010): Novasep, a leading supplier of manufacturing solutions to the life sciences industries, and Provepharm, a start-up specialized in the development of pharmaceutical applications for Proveblue®, announce today the successful validation by Novasep of a cGMP... Read more
Agenda 1 launch training and recruitment affiliate
Agenda 1 Analytical Services Ltd (22nd January 2010): Agenda 1 Analytical Services Ltd recently announced the formation and launch of Agenda 1 Scientific Training and Recruitment Ltd (Agenda 1 STaR). This company is lead by Simon Ackroyd, with many years experience in the industry and supported by a team... Read more
UK-BASED SCM Pharma has launched a commercial supply service.
SCM Pharma Ltd (22nd January 2010): UK-BASED SCM Pharma has launched a commercial supply service and has already secured its first long-term ongoing contracts. The contract manufacturing organisation (CMO), which has built a world-class reputation for clinical trial development and... Read more
Strengthening of leadership team to prepare Pharma business for spin-out
Crystallics BV (4th January 2010): Avantium appoints Gunnar Staaf as CEO Pharma December 16, 2009, Amsterdam, The Netherlands Today, Avantium announced the appointment of Gunnar Staaf as Chief Executive Officer of its pharmaceutical business. Gunnar Staaf previously worked at Serentis... Read more
Crystal Structure Prediction: a new service opening up exciting possibilities for the pharmaceutical industry
Crystallics BV (4th January 2010): Avantium and AMS start collaboration to develop and commercialize Crystal Structure Prediction November 6, 2009 - Amsterdam, The Netherlands and Freiburg, Germany Avantium and Avant-garde Materials Simulations (AMS) announced today that they have... Read more
Avantium successfully delivers Solid State Research Workflow to Daiichi Sankyo
Crystallics BV (4th January 2010): 15 October 2009 - Amsterdam, The Netherlands Avantium announced today that, in partnership with Mitsubishi Corporation, it has entered into a technology transfer agreement with Daiichi Sankyo Company Limited. Under this agreement Avantium supplies its... Read more
Pharmaterials add Xcelodose
Pharmaterials Ltd (9th November 2009): As part of our “First in Man Fast” approach, Pharmaterials are delighted to offer cGMP precision powder filling into capsules using Xcelodose® contract manufacturing in our UK facility. This technology can be used to fill small quantities of API alone... Read more
CML Expands Capacity in Europe and the US
Cambridge Major Laboratories (21st October 2009): CML is proud to announce the commissioning of additional capacity on both continents. A new state-of-the-art production facility, containing 6 fully segregated reactor suites with total capacity 70.000L, is now in operation in Wisconsin. This is a world-class... Read more
Solvias AG wins European Outsourcing Award 2009
Solvias AG (20th October 2009): The award was received in the category “Best Analytical Contract Project”. Solvias performed the complete analysis within strict deadlines for the CMC documentation for IDM Pharma’s orphan medicinal product MEPACT®. The combination of professional project... Read more
Solvias AG and SARcode Corporation Announce Chemical Development and GMP Manufacturing Agreement
Solvias AG (13th October 2009): Solvias AG and SARcode Corporation have entered into an expanded agreement for the chemical development and manufacturing of SARcode›s active pharmaceutical ingredient (API) SAR 1118. Solvias will provide ongoing process R&D support and deliver SAR 1118... Read more
Novasep gains SafeBridge® "Potent Compound Safety Certification" for its Le Mans facility
Novasep (17th September 2009): Novasep is pleased to announce that its site in Le Mans - France, specialized in the development and manufacturing of Highly Potent Active Pharmaceutical Ingredients (HPAIs), has received the “Potent Compound Safety Certification” from SafeBridge® Consultants,... Read more
Sygnature Chemical Services Awarded £390,000 Grant for Business Investment by emda
Sygnature CSL (15th September 2009): Nottingham, UK – July 27th, 2009 – Sygnature Chemical Services Ltd., a leading provider of medicinal chemistry and computational chemistry services to the global pharmaceutical industry, has been awarded a £390,000 Grant for Business Investment (GBI)... Read more
Sygnature Chemical Services Strengthens Leadership Team; Dr. Paul Clewlow Appointed as Senior Vice-President, Business D
Sygnature CSL (15th September 2009): Nottingham, UK 6th April 2009 – Sygnature Chemical Services Ltd., a leading provider of medicinal chemistry, synthetic chemistry and chemical library services, is pleased to announce the appointment of Dr. Paul Clewlow as Senior Vice-President, Business... Read more
Sygnature Chemical Services Announces New Appointments to the Board of Directors
Sygnature CSL (15th September 2009): Nottingham, UK 6th April 2009 – Sygnature Chemical Services is pleased to announce two new appointments to the Board of Directors: Dr Jonathan G Williams becomes Director of Operations following four years as Principle Research Chemist at Sygnature... Read more
Sygnature Chemical Services Extends its Research Facilities Again in BioCity Nottingham
Sygnature CSL (15th September 2009): Nottingham, UK 6th April 2009 – Due to an unprecedented demand for its contract medicinal chemistry services, Sygnature Chemical Services has already outgrown the purpose-designed and built laboratory and office space occupied during the £1M expansion... Read more
Recent expansion at High Force Research ltd
High Force Research Ltd (14th September 2009): Investment in analytical capabilities coupled with current and planned additional personnel backed by the award of a Grant for Business Investment (GBI) from One North East, with support from the European Regional Development Fund, has seen High Force... Read more
Swissmedic grants Solvias approval to manufacture APIs for clinical trials
Solvias AG (1st September 2009): Solvias complements its services with a new GMP kilo laboratory. The first custom manufacturing campaign for an active pharmaceutical ingredient (API) will start this month. The newly designed and approved facility complements the existing kilo laboratory... Read more
Solvias Completes a Major Manufacturing Campaign for Rolic Technologies Ltd.
Solvias AG (27th August 2009): Solvias delivered more than 200 kg of a key component, meeting Rolic’s very high quality expectations for application in their photo alignment technology. Commencing with initial process research and development, Solvias moved the campaign swiftly... Read more
Novasep acquires bioprocess development specialist and contract manufacturer Henogen
Novasep (2nd July 2009): Pompey, France, July 2, 2009 - Novasep, a leading producer of active pharmaceutical ingredients (APIs) and purification technologies for the life science industries, announces today the acquisition of Henogen, a contract manufacturing organization (CMO)... Read more
Solvias Announces Construction of cGMP Kilo Lab in Basel (Switzerland)
Solvias AG (29th October 2008): Solvias has announced the construction of its new kg-scale cGMP manufacturing plant in Basel, which is planned to be operational within Q2/09. The facility will complement the existing state-of-the-art kilo lab by rapid and cost-effective manufacturing... Read more